Nuo Therapeutics, Inc. (AURX) Free cash flow 2015–2025
Nuo Therapeutics, Inc. (AURX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$1.1MFY2025 · since FY2015: -$15.1M → -$1.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$1.1M | +52.2% |
| FY2024 | -$2.4M | +24.8% |
| FY2023 | -$3.2M | +15.7% |
| FY2022 | -$3.8M | -3039.6% |
| FY2021 | -$119,955 | -122.9% |
| FY2020 | -$53,821 | +94.2% |
| FY2019 | -$921,674 | — |
| FY2015 | -$15.1M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice